إعلان
إعلان

INSM

INSM logo

Insmed, Inc.

170.29
USD
برعاية
-5.71
-3.24%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

170.09

-0.20
-0.12%

تقارير أرباح INSM

النسبة الإيجابية المفاجئة

INSM تفوق 15 من 40 آخر التقديرات.

38%

التقرير التالي

بيانات التقرير القادم
١٨ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$174.83M
/
-$1.33
التغير الضمني من Q3 25 (Revenue/ EPS)
+22.83%
/
-24.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+67.40%
/
+0.76%

Insmed, Inc. earnings per share and revenue

On ٣٠ أكتوبر ٢٠٢٥, INSM reported earnings of -1.75 USD per share (EPS) for Q3 25, missing the estimate of -1.36 USD, resulting in a -28.09% surprise. Revenue reached 142.34 مليون, compared to an expected 117.92 مليون, with a 20.71% difference. The market reacted with a +16.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 المحللين forecast an EPS of -1.33 USD, with revenue projected to reach 174.83 مليون USD, implying an نقصان of -24.00% EPS, and زيادة of 22.83% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Insmed, Inc. reported EPS of -$1.75, missing estimates by -28.09%, and revenue of $142.34M, 20.71% above expectations.
The stock price moved up 16.33%, changed from $166.95 before the earnings release to $194.22 the day after.
The next earning report is scheduled for ١٨ فبراير ٢٠٢٦.
Based on 19 المحللين, Insmed, Inc. is expected to report EPS of -$1.33 and revenue of $174.83M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان